Drugs Index
Medical Conditions:
- Medical Conditions G
- Medical Conditions I
- Medical Conditions P
- Medical Conditions C
- Medical Conditions N
- Medical Conditions T
- Medical Conditions E
- Medical Conditions D
- Medical Conditions F
- Medical Conditions H
- Medical Conditions M
- Medical Conditions B
- Medical Conditions U
- Medical Conditions O
- Medical Conditions S
- Medical Conditions A
- Medical Conditions R
- Medical Conditions L
- Medical Conditions W
- Medical Conditions V
- Medical Conditions K
- Medical Conditions J
- Medical Conditions X
Drug Classes
- Drug Classes A
- Drug Classes M
- Drug Classes H
- Drug Classes C
- Drug Classes B
- Drug Classes U
- Drug Classes T
- Drug Classes O
- Drug Classes I
- Drug Classes N
- Drug Classes V
- Drug Classes E
- Drug Classes G
- Drug Classes P
- Drug Classes L
- Drug Classes Q
- Drug Classes F
- Drug Classes S
- Drug Classes D
- Drug Classes R
- Drug Classes 5
- Drug Classes K
Drugs Information:
Drugs List
Zanaflex is a brand name of tizanidine, approved by the FDA in the following formulation(s):
ZANAFLEX (tizanidine hydrochloride - capsule; oral)
-
Manufacturer: ACORDA
Approval date: August 29, 2002
Strength(s): EQ 2MG BASE [AB], EQ 4MG BASE [AB], EQ 6MG BASE [RLD][AB]
ZANAFLEX (tizanidine hydrochloride - tablet; oral)
-
Manufacturer: ACORDA
Approval date: November 27, 1996
Strength(s): EQ 4MG BASE [RLD][AB]
Has a generic version of Zanaflex been approved?
A generic version of Zanaflex has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Zanaflex and have been approved by the FDA:
tizanidine hydrochloride capsule; oral
-
Manufacturer: APOTEX INC
Approval date: February 3, 2012
Strength(s): EQ 2MG BASE [AB], EQ 4MG BASE [AB], EQ 6MG BASE [AB]
tizanidine hydrochloride tablet; oral
-
Manufacturer: ALPHAPHARM
Approval date: December 16, 2003
Strength(s): EQ 4MG BASE [AB] -
Manufacturer: APOTEX
Approval date: January 16, 2004
Strength(s): EQ 4MG BASE [AB] -
Manufacturer: CARACO
Approval date: September 29, 2003
Strength(s): EQ 4MG BASE [AB
Plaquenil is a brand name of hydroxychloroquine, approved by the FDA in the following formulation(s):
PLAQUENIL (hydroxychloroquine sulfate - tablet; oral)
-
Manufacturer: SANOFI AVENTIS US
Approved Prior to Jan 1, 1982
Strength(s): 200MG [RLD][AB]
Has a generic version of Plaquenil been approved?
Yes. The following products are equivalent to Plaquenil:
hydroxychloroquine sulfate tablet; oral
-
Manufacturer: IPCA LABS LTD
Approval date: June 14, 2007
Strength(s): 200MG [AB] -
Manufacturer: MYLAN
Approval date: May 29, 1998
Strength(s): 200MG [AB] -
Manufacturer: SANDOZ
Approval date: November 30, 1995
Strength(s): 200MG [AB] -
Manufacturer: SANDOZ
Approval date: January 27, 1996
Strength(s): 200MG [AB] -
Manufacturer: TEVA PHARMS
Approval date: September 30, 1994
Strength(s): 200MG [AB] -
Manufacturer: WATSON LABS
Approval date: November 30, 1995
Strength(s): 200MG [AB] -
Manufacturer: WEST WARD
Approval date: August 15, 2007
Strength(s): 200MG [AB] -
Manufacturer: ZYDUS PHARMS USA INC
Approval date: September 21, 2007
Strength(s): 200MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Plaquenil. These medications may be counterfeit and potentially un
Peganone is a brand name of ethotoin, approved by the FDA in the following formulation(s):
PEGANONE (ethotoin - tablet; oral)
-
Manufacturer: LUNDBECK INC
Approved Prior to Jan 1, 1982
Strength(s): 250MG [RLD]
Has a generic version of Peganone been approved?
No. There is currently no therapeutically equivalent version of Peganone available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Peganone. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Peganone.
See also...
- Peganone Consumer Information (Wolters Kluwer)
- Peganone Consumer Information (Cerner Multum)
- Peganone Advanced Consumer Information (Micromedex)
- Ethotoin Consumer Information (Wolters Kluwer)
- Ethotoin Consumer Information (Cerner Multum)
- Ethotoin Advanced Consumer Information (Micromedex)
Ancobon is a brand name of flucytosine, approved by the FDA in the following formulation(s):
ANCOBON (flucytosine - capsule; oral)
-
Manufacturer: VALEANT
Approved Prior to Jan 1, 1982
Strength(s): 250MG [AB], 500MG [RLD][AB]
Has a generic version of Ancobon been approved?
Yes. The following products are equivalent to Ancobon:
flucytosine capsule; oral
-
Manufacturer: SIGMAPHARM LABS LLC
Approval date: June 28, 2011
Strength(s): 250MG [AB], 500MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ancobon. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Ancobon.
See also...
- Ancobon Consumer Information (Wolters Kluwer)
- Ancobon Consumer Information (Cerner Multum)
- Ancobon Advanced Consumer Information (Micromedex)
- Ancobon AHFS DI Monographs (ASHP)
- Flucytosine Consumer Information (Wolters Kluwer)
- Flucytosine Consumer Information (Cerner Multum)
- Flucytosine Advanced Consumer Information (Micromedex)
- Flucytosine AHFS DI Monographs (ASHP)
Urocit-K is a brand name of potassium citrate, approved by the FDA in the following formulation(s):
UROCIT-K (potassium citrate - tablet, extended release; oral)
-
Manufacturer: MISSION PHARMA
Approval date: August 30, 1985
Strength(s): 5MEQ [AB] -
Manufacturer: MISSION PHARMA
Approval date: August 31, 1992
Strength(s): 10MEQ [AB] -
Manufacturer: MISSION PHARMA
Approval date: December 30, 2009
Strength(s): 15MEQ [RLD]
Has a generic version of Urocit-K been approved?
Yes. The following products are equivalent to Urocit-K:
potassium citrate tablet, extended release; oral
-
Manufacturer: COREPHARMA
Approval date: June 9, 2006
Strength(s): 10MEQ [AB], 5MEQ [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Urocit-K. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Urocit-K.
See also...
- Urocit-K Consumer Information (Wolters Kluwer)
- Urocit-K Consumer Information (Cerner Multum)
- Potassium Consumer Information (Drugs.com)
- Potassium Citrate Consumer Information (Wolters Kluwer)
- Potassium citrate Consumer Information (Cerner Multum)
- Urocit-K 10 Oral Advance
See also: Generic Terazol 7
Terazol 3 is a brand name of terconazole topical, approved by the FDA in the following formulation(s):
TERAZOL 3 (terconazole - cream; vaginal)
-
Manufacturer: JANSSEN PHARMS
Approval date: February 21, 1991
Strength(s): 0.8% [RLD][AB]
Has a generic version of Terazol 3 been approved?
Yes. The following products are equivalent to Terazol 3:
terconazole cream; vaginal
-
Manufacturer: TARO
Approval date: April 6, 2004
Strength(s): 0.8% [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Terazol 3. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Terazol 3.
See also...
- Terazol 3 Suppositories Consumer Information (Wolters Kluwer)
- Terazol 3 Consumer Information (Cerner Multum)
- Terconazole Cream Consumer Information (Wolters Kluwer)
- Terconazole Suppositories Consumer Information (Wolters Kluwer)
- Terconazole vaginal Consumer Information (Cerner Multum)
- Terconazole AHFS DI Monographs (ASHP)
Prometrium is a brand name of progesterone, approved by the FDA in the following formulation(s):
PROMETRIUM (progesterone - capsule; oral)
-
Manufacturer: ABBOTT LABS
Approval date: May 14, 1998
Strength(s): 100MG -
Manufacturer: ABBOTT LABS
Approval date: October 15, 1999
Strength(s): 200MG [RLD]
Has a generic version of Prometrium been approved?
No. There is currently no therapeutically equivalent version of Prometrium available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Prometrium. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Prometrium.
See also...
- Prometrium Consumer Information (Wolters Kluwer)
- Prometrium Consumer Information (Cerner Multum)
- Progesterone Consumer Information (Drugs.com)
- Progesterone Consumer Information (Wolters Kluwer)
- Progesterone Gel Consumer Information (Wolters Kluwer)
- Progesterone Insert Consumer Information (Wolters Kluwer)
- Progesterone Oil Consumer Information (Wolters Kluwer)
- FIRST-Progesterone VGS 100 Consumer Information (Cerner Multum)
- FIRST-Progesterone VGS 200 Consumer Information (Cerner Multum)
- FIRST-Progesterone VGS 25 Consumer Information (Cerner Multum)
- FIRST-Progesterone VGS 400 Consumer Inf
Sutent is a brand name of sunitinib, approved by the FDA in the following formulation(s):
SUTENT (sunitinib malate - capsule; oral)
-
Manufacturer: CPPI CV
Approval date: January 26, 2006
Strength(s): EQ 12.5MG BASE, EQ 25MG BASE, EQ 50MG BASE [RLD] -
Manufacturer: CPPI CV
Approval date: March 31, 2009
Strength(s): EQ 37.5MG BASE
Has a generic version of Sutent been approved?
No. There is currently no therapeutically equivalent version of Sutent available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Sutent. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
-
Pyrrole substituted 2-indolinone protein kinase inhibitors
Patent 6,573,293
Issued: June 3, 2003
Inventor(s): Peng Cho; Tang & Todd A.; Miller & Xiaoyuan; Li & Li; Sun & Chung Chen; Wei & Shahrzad; Shirazian & Congxin; Liang & Tomas; Vojkovsky & Asaad S.; Nematalla & Michael; Hawley
Assignee(s): Sugen, Inc. Pharmacia & Upjohn Co.
The present invention relates to pyrrole substituted 2-indolinone compounds and their pharmaceutically acceptable salts which modulate the activity of protein kinases and therefore are expected to be useful in the prevention and treatment of protein kinase related cellular disorders such as cancer.
BiDil is a brand name of hydralazine/isosorbide dinitrate, approved by the FDA in the following formulation(s):
BIDIL (hydralazine hydrochloride; isosorbide dinitrate - tablet; oral)
-
Manufacturer: ARBOR PHARMS INC
Approval date: June 23, 2005
Strength(s): 37.5MG;20MG [RLD]
Has a generic version of BiDil been approved?
No. There is currently no therapeutically equivalent version of BiDil available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of BiDil. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
-
Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
Patent 6,465,463
Issued: October 15, 2002
Inventor(s): Jay N.; Cohn & Peter; Carson
Assignee(s): NitroMed, Inc.
The present invention provides methods or treating and preventing mortality associated with heart failure in an African American patient with hypertension and improving oxygen consumption, quality of life and exercise tolerance by administering a therapeutically effective amount of at least one hydralazine compound and at least one of isosorbide dinitrate and isosorbide mononitrate, and, optionally, one or more compounds, such as, for example, a digitalis, a diuretic compound, or a compound used to treat cardiovascular diseases. In the present inve
Ultracet is a brand name of acetaminophen/tramadol, approved by the FDA in the following formulation(s):
ULTRACET (acetaminophen; tramadol hydrochloride - tablet; oral)
-
Manufacturer: JANSSEN PHARMS
Approval date: August 15, 2001
Strength(s): 325MG;37.5MG [RLD][AB]
Has a generic version of Ultracet been approved?
A generic version of Ultracet has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Ultracet and have been approved by the FDA:
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN (acetaminophen; tramadol hydrochloride tablet; oral)
-
Manufacturer: AMNEAL PHARMS
Approval date: December 9, 2009
Strength(s): 325MG;37.5MG [AB] -
Manufacturer: CARACO
Approval date: December 16, 2005
Strength(s): 325MG;37.5MG [AB] -
Manufacturer: MYLAN
Approval date: September 26, 2008
Strength(s): 325MG;37.5MG [AB] -
Manufacturer: PAR PHARM
Approval date: April 21, 2005
Strength(s): 325MG;37.5MG [AB] -
Manufacturer: WATSON LABS
Approval date: July 26, 2006
Strength(s): 325MG;37.5MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Ultracet. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and va
Silenor is a brand name of doxepin, approved by the FDA in the following formulation(s):
SILENOR (doxepin hydrochloride - tablet; oral)
-
Manufacturer: SOMAXON
Approval date: March 17, 2010
Strength(s): EQ 3MG BASE, EQ 6MG BASE [RLD]
Has a generic version of Silenor been approved?
No. There is currently no therapeutically equivalent version of Silenor available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Silenor. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
-
Treatment for insomnia
Patent 5,502,047
Issued: March 26, 1996
Inventor(s): Kavey; Neil B.
A method for the treatment of chronic insomnia is disclosed which involves the administration of low dosages of a compound selected from the pharmaceutically acceptable forms of doxepin, trimipramine, amitriptyline, trazodone and mixtures hereof.Patent expiration dates:- March 26, 2013?
- March 26, 2013
-
Pharmaceutical excipient having improved compressability
Patent 5,585,115
Issued: December 17, 1996
Inventor(s): Sherwood; Bob E. & Hunter; Edward A. & Staniforth; John H.
Assignee(s): Edward H. Mendell Co.,
Zyrtec is a brand name of cetirizine, approved by the FDA in the following formulation(s):
ZYRTEC (cetirizine hydrochloride - syrup; oral)
-
Manufacturer: MCNEIL CONSUMER
Approval date: September 27, 1996
Strength(s): 5MG/5ML [RLD][AA]
Has a generic version of Zyrtec been approved?
Yes. The following products are equivalent to Zyrtec:
cetirizine hydrochloride syrup; oral
-
Manufacturer: AMNEAL PHARMS
Approval date: October 7, 2009
Strength(s): 5MG/5ML [AA] -
Manufacturer: APOTEX INC
Approval date: June 18, 2008
Strength(s): 5MG/5ML [AA] -
Manufacturer: AUROBINDO PHARMA
Approval date: December 16, 2009
Strength(s): 5MG/5ML [AA] -
Manufacturer: CYPRESS PHARM
Approval date: October 6, 2008
Strength(s): 5MG/5ML [AA] -
Manufacturer: DR REDDYS LABS LTD
Approval date: April 27, 2009
Strength(s): 5MG/5ML [AA] -
Manufacturer: PERRIGO R AND D
Approval date: June 17, 2008
Strength(s): 5MG/5ML [AA] -
Manufacturer: RANBAXY
Approval date: June 18, 2008
Strength(s): 5MG/5ML [AA] -
Manufacturer: SUN PHARM INDS INC
Approval date: November 12, 2009
Strength(s): 5MG/5ML [AA] -
Manufacturer: TARO
Approval date: June 20, 2008
Strength(s): 5MG/5ML [AA] -
Manufacturer: TEVA PHARMS
See also: Generic Pamine Forte
Pamine is a brand name of methscopolamine, approved by the FDA in the following formulation(s):
PAMINE (methscopolamine bromide - tablet; oral)
-
Manufacturer: FOUGERA PHARMS
Approved Prior to Jan 1, 1982
Strength(s): 2.5MG [RLD][AA]
Has a generic version of Pamine been approved?
Yes. The following products are equivalent to Pamine:
methscopolamine bromide tablet; oral
-
Manufacturer: BOCA PHARMA
Approval date: December 28, 2006
Strength(s): 2.5MG [AA] -
Manufacturer: BRECKENRIDGE PHARM
Approval date: December 6, 2011
Strength(s): 2.5MG [AA]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Pamine. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Pamine.
See also...
- Pamine Consumer Information (Wolters Kluwer)
- Pamine Consumer Information (Cerner Multum)
- Pamine AHFS DI Monographs (ASHP)
- Methscopolamine Consumer Information (Wolters Kluwer)
- Methscopolamine Consumer Information (Cerner Multum)
- Methscopolamine Bromide AHFS DI Monographs (ASHP)
EryPed is a brand name of erythromycin, approved by the FDA in the following formulation(s):
ERYPED (erythromycin ethylsuccinate - granule; oral)
-
Manufacturer: ARBOR PHARMS INC
Approved Prior to Jan 1, 1982
Strength(s): EQ 400MG BASE/5ML [RLD] -
Manufacturer: ARBOR PHARMS INC
Approval date: March 30, 1987
Strength(s): EQ 200MG BASE/5ML [AB]
Has a generic version of EryPed been approved?
No. There is currently no therapeutically equivalent version of EryPed available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of EryPed. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with EryPed.
See also...
- EryPed Drops Consumer Information (Wolters Kluwer)
- EryPed Suspension Consumer Information (Wolters Kluwer)
- EryPed Consumer Information (Cerner Multum)
- EryPed 200 Consumer Information (Cerner Multum)
- EryPed 400 Consumer Information (Cerner Multum)
- Eryped Advanced Consumer Information (Micromedex)
- Eryped 200 Advanced Consumer Information (Micromedex)
- Eryped 400 Advanced Consumer Information (Micromedex)
- Erythromycin Consumer Information (Drugs.com)
- E. E. S. Suspension Consumer Information (Wolters Kluwer)
- Erythromycin Consumer Information (Wo
Atrovent HFA is a brand name of ipratropium, approved by the FDA in the following formulation(s):
ATROVENT HFA (ipratropium bromide - aerosol, metered; inhalation)
-
Manufacturer: BOEHRINGER INGELHEIM
Approval date: November 27, 2004
Strength(s): 0.021MG/INH [RLD]
Has a generic version of Atrovent HFA been approved?
No. There is currently no therapeutically equivalent version of Atrovent HFA available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Atrovent HFA. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
-
Stabilized medicinal aerosol solution formulations
Patent 5,676,930
Issued: October 14, 1997
Inventor(s): Jager; Paul Donald & Kontny; Mark James & Nagel; Jurgen Hubert
Assignee(s): Boehringer Ingelheim Pharmaceuticals, Inc.
Stabilized medicinal aerosol solution formulations comprising medicaments that degrade or decompose by interaction with solvents or water, an HFC propellant, a cosolvent and an acid are described. Further, specific medicinal aerosol solution formulations comprising ipratropium bromide or fenoterol, ethyl alcohol, 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoropropane, and either an inorganic acid or an organic acid are described. The acids are present in amounts sufficient to reduce the degradation of the medicaments to acceptable levels.
Edluar is a brand name of zolpidem, approved by the FDA in the following formulation(s):
EDLUAR (zolpidem tartrate - tablet; sublingual)
-
Manufacturer: MEDA PHARMS
Approval date: March 13, 2009
Strength(s): 10MG [RLD], 5MG
Has a generic version of Edluar been approved?
No. There is currently no therapeutically equivalent version of Edluar available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Edluar. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
-
Pharmaceutical composition for the treatment of acute disorders
Patent 6,761,910
Issued: July 13, 2004
Inventor(s): Anders; Pettersson & Christer; Nystrom
Assignee(s): Diabact AB
A pharmaceutical composition for the treatment of acute disorders is described. The composition comprises an essentially water-free, ordered mixture of at least one pharmaceutically active agent in the form of microparticles which are adhered to the surfaces of carrier particles which are substantially larger than the particles of the active agent or agents, and are essentially water-soluble, in combination with the bioadhesion and/or mucoadhesion promoting agent. The invention also relates to a method for preparing the composition and to the use of the composition for the treatment of acute disorders.
See also: Generic Zofran
Zofran ODT is a brand name of ondansetron, approved by the FDA in the following formulation(s):
ZOFRAN ODT (ondansetron - tablet, orally disintegrating; oral)
-
Manufacturer: GLAXOSMITHKLINE
Approval date: January 27, 1999
Strength(s): 4MG [AB], 8MG [RLD][AB]
Has a generic version of Zofran ODT been approved?
A generic version of Zofran ODT has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Zofran ODT and have been approved by the FDA:
ondansetron tablet, orally disintegrating; oral
-
Manufacturer: AUROBINDO PHARMA
Approval date: April 12, 2010
Strength(s): 4MG [AB], 8MG [AB] -
Manufacturer: BARR
Approval date: June 25, 2007
Strength(s): 4MG [AB], 8MG [AB] -
Manufacturer: GLENMARK GENERICS
Approval date: June 27, 2007
Strength(s): 4MG [AB], 8MG [AB] -
Manufacturer: MYLAN
Approval date: June 25, 2007
Strength(s): 4MG [AB], 8MG [AB] -
Manufacturer: NESHER PHARMS
Approval date: June 25, 2007
Strength(s): 4MG [AB], 8MG [AB] -
Manufacturer: PAR PHARM
Approval d
See also: Generic FML Forte Liquifilm
FML is a brand name of fluorometholone ophthalmic, approved by the FDA in the following formulation(s):
FML (fluorometholone - ointment; ophthalmic)
-
Manufacturer: ALLERGAN
Approval date: September 4, 1985
Strength(s): 0.1% [RLD]
FML (fluorometholone - suspension/drops; ophthalmic)
-
Manufacturer: ALLERGAN
Approval date: July 28, 1982
Strength(s): 0.1% [RLD]
Has a generic version of FML been approved?
No. There is currently no therapeutically equivalent version of FML available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of FML. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with FML.
See also...
- FML Ointment Consumer Information (Wolters Kluwer)
- Fluorometholone Consumer Information (Wolters Kluwer)
- Fluorometholone Acetate Suspension Consumer Information (Wolters Kluwer)
- Fluorometholone Ointment Consumer Information (Wolters Kluwer)
- Fluorometholone ophthalmic Consumer Information (Cerner Multum)
- Fluorometholone AHFS DI Monographs (ASHP)
Vanos is a brand name of fluocinonide topical, approved by the FDA in the following formulation(s):
VANOS (fluocinonide - cream; topical)
-
Manufacturer: MEDICIS
Approval date: February 11, 2005
Strength(s): 0.1% [RLD]
Has a generic version of Vanos been approved?
No. There is currently no therapeutically equivalent version of Vanos available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Vanos. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
-
Compositions and methods for enhancing corticosteroid delivery
Patent 6,765,001
Issued: July 20, 2004
Inventor(s): Eugene H.; Gans & Mitchell S.; Wortzman
Assignee(s): Medicis Pharmaceutical Corporation
The present invention comprises a composition, method of enhancing potency and method of delivering corticosteroids in a vehicle comprising at least two penetration enhancers, and solvents and emulsifiers. The propylene glycol and penetration enhancers are present in ratio to the total of the propylene glycol, penetration enhancers, and solvents and emulsifiers of at least about 0.70.Patent expiration dates:- December 21, 2021?
- December 21, 2021
- Composition
See also: Generic Acular, Generic Acular PF
Acular LS is a brand name of ketorolac ophthalmic, approved by the FDA in the following formulation(s):
ACULAR LS (ketorolac tromethamine - solution/drops; ophthalmic)
-
Manufacturer: ALLERGAN
Approval date: May 30, 2003
Strength(s): 0.4% [RLD][AT]
Has a generic version of Acular LS been approved?
A generic version of Acular LS has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Acular LS and have been approved by the FDA:
ketorolac tromethamine solution/drops; ophthalmic
-
Manufacturer: AKORN
Approval date: November 5, 2009
Strength(s): 0.4% [AT] -
Manufacturer: ALCON PHARMS LTD
Approval date: November 5, 2009
Strength(s): 0.4% [AT] -
Manufacturer: APOTEX INC
Approval date: November 5, 2009
Strength(s): 0.4% [AT]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Acular LS. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a